TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV

05.08.2008 18:40:05
Tibotec Pharmaceuticals Ltd.: Mexico City, Mexico (ots/PRNewswire) - - Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008 New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company's once-daily, ...

Lesen Sie hier weiter... | Drucken | PDF

Ähnliche Artikel

Recruitment Ongoing in Europe for Two Tibotec Phase III Clinical Trials Studying TMC278 in Treatment-Naïve HIV-Infected Adults
Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
New Data Show Duloxetine Maintained Pain Reduction for More Than Six Months in Patients With Diabetic Peripheral Neuropathic Pain
First Landmark ARB Trial Against Placebo Shows MICARDIS(R) (Telmisartan) Reduces the Risk of Cardiovascular Death, Heart Attack and Stroke in ACE-Intolerant High-Risk Patients(1)
Telmisartan (MICARDIS(R)) as Effective as Ramipril But With Better Long-Term Tolerability in High-Risk Cardiovascular Asian Patients
Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer
Renewed Hope for a Cure: Extending Pegasys Treatment to 72 Weeks Provides New Treatment Option for Difficult-to-Treat Hepatitis C Patients
Roche's R1626, First-in-Class Hepatitis C Polymerase Inhibitor, Demonstrates Impressive End-of-Treatment Response in Phase IIa Study
PREZISTA(R) (darunavir) Receives Expanded Marketing Authorisation in the European Union for Treatment-Experienced Adults With HIV-1

fit4fonds.de/<b>TMC278</b>-<b>Demonstrates</b>-<b>Long</b>-<b>Term</b>-<b>Efficacy</b>-and-Tolerability-in-<b>...</b>

TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Na? Efficacy and Tolerability in Treatment-Naïve Adults With HIV vor 11 Wochen, 5 T

scouty.de/n2362700-<b>tmc278</b>-<b>demonstrates</b>-<b>long</b>-<b>term</b>-<b>efficacy</b>-and-tolerabili<b>...</b>

TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV and tolerability in treatment-naïve adults with HIV.Ninety-six-week

treatment - SCOUTy.de - Dein Nachrichten Scout.

TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Na ...